GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lee's Pharmaceutical Holdings 950.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

1.07

+0.94%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Lee's Pharmaceutical Holdings

Its shares trade on HKEX under the ticker 950.HK. It has been listed since 15 July 2002. In the fiscal year to 31 December 2024, it reported revenue of HK$1.40bn and net income of HK$93.1m. At that date it held total assets of HK$2.62bn and shareholders' equity of HK$1.65bn.

Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacture and sale of pharmaceutical products. The company employs 1,417 full-time employees The company went IPO on 2002-07-15. The firm operates through two segments. Proprietary Products segment is engaged in the manufacture and sales of self-developed pharmaceutical products. Its proprietary products include Yallaferon, Livaracine and Slounase, among others. Licensed-in Products segment is engaged in the trading of licensed-in pharmaceutical products. Its licensed-in products include Ferplex and Zanidip, among others. The Company’s products are for cardiovascular and infectious diseases, dermatology, oncology, gynecology and ophthalmology, among others. The firm mainly operates businesses in China and Hong Kong.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
15 Jul 2002
Employees
1,417

Leadership

Pay as last reported

  • Ms. Siu Fong LeeExecutive Chairman of the BoardHK$12.2m
  • Ms. Wanee LeelalertsuphakunManaging Director, Chief Marketing and Sales Officer, Executive Director, since 2003HK$13.2m
  • Mr. Zhongyu JiaoGeneral Manager of the Risk Control Centre, Group Deputy General Manager, since 2021
  • Mr. Zeyun ZhangGeneral Manager of the Group Commercial Operations Centre and Executive Deputy General Manager of Guangzhou Zhaoke Lian Fa Pharmaceutical Limited, since 2022
  • Mr. Yueshen ChenDirector of Administration - China, since 2020
  • Ms. Ling FangCorporate Culture and Public Relations Director of the Group
  • Mr. Tsui VictorChief Manufacturing Officer, Licensed Professional Engineer
  • Ms. Hongling XiaDeputy General Manager of Zhaoke Pharmaceutical (Hefei) Co. Limited
  • Mr. Zhongqiang YangExecutive Deputy General Manager of Zhaoke Pharmaceutical (Hefei) Co. Limited
  • Mr. Lei YinAssociate Director, R&D of the Group
  • Ms. Chengping ZhongDeputy General Manager of Zhaoke Pharmaceutical (Guangzhou) Limited
  • Mr. Yiu Ming ChowGroup Chief Financial Officer, Company Secretary

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.